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Dear Professor Paolo G. Camici, Editor in Chief,
We thank the Editorial Committee and the Reviewer for their valuable comments on 
the manuscript entitled ‘Sex differences in rates and causes of 30-day readmissions after 
cardiac electronic device implantations: insights from the Nationwide Readmissions 
Database.’ We feel that these comments have improved the quality of our manuscript. We have 
attempted to answer all the comments fully as outlined in the rebuttal and tracked all new 
changes in the manuscript.
We hope that we have addressed all reviewers’ comments sufficiently and hope that 
these changes will enable publication of our paper in the International Journal of Cardiology.
Yours sincerely
Dr Mohamed Mohamed and Prof. Mamas Mamas
On behalf of submitting authors




Well-written observational registry analysis of readmissions after CIED implantations, 
focusing on differences between sex. Females had more readmissions for cardiac causes, but 
not for all-causes in adjusted analysis. 
Comment 1. Major: Why did the study period end in 2015? There is a trend towards declining 
readmission rates and differences between sexes being less over the period 2010-2015. Would 
strengthen the data very much to include contemporary data also.
Response: We thank the reviewer for their interest in our paper and for their comments. In the cases 
of national databases such as NRD, there is always have a 2-year between the time that 
hospitalizations surveyed and their public release for their purpose of research. The most recent 
NRD year accessible to researchers as of today is 2016 (link: https://www.distributor.hcup-
us.ahrq.gov/Databases.aspx ). However, starting from the final quarter of 2015, NRD has moved to 
a new coding system (ICD-10), which classifies certain comorbidities, procedures and 
complications in a different way to ICD-9, the coding system used in the present study. Therefore, 
other than the fact that we didn’t have access to 2016, we also didn’t consider using it for the purpose 
of this study so as to have a homogenous cohort using a unified coding system. We fully agree with 
the reviewer in that more longitudinal analysis would be useful and we hope to do this once more 
calendar years are available for research purposes. 
Comment 2. Abstract: Must be clear that the OR's are from adjusted analysis. Otherwise, it 
is not easy to understand why female had more re-admissions, but the OR for all-cause 
readmissions was not different from 1.0.
Response: We have now updated the abstract to clarify that the OR’s are adjusted (aOR). 
Reviewer 2
This is an interesting article regarding Sex differences in rates and causes of 30-day 
readmissions after cardiac electronic device implantations: insights from the NRD by a team 
with an important experience in the field of big data. 
There are some issues that should be clarified to improve the quality of the manuscript:
Comment 1.- Supp Fig 2: It looks like that ICD readmissions due to CV are higher in men that 
in women, how can we interpret this finding regarding to the results of CRT / PPM?
Response: As the reviewer kindly noted, Supplementary Figure 2 (soon to be a main figure as per 
the reviewer’s second comment) illustrates readmission causes according to device subtype. We 
observe that CV readmission rates are higher in men in the ICD subgroup, but lower in the PPM 
and CRT-P groups, whereas no difference was found in the CRT-D group. The higher CV 
readmission rates in women in the PPM and CRT-P groups could be explained their higher 
prevalence of heart failure and AF as observed in our analysis of baseline characteristics according 
to device subgroups (now added to the supplements as Supplementary Table 3). Indeed we observe 
that readmissions due to arrhythmias and heart failure were higher in women in the PPM (9.2% vs. 
6.6% and 15.4% vs. 12.4%, respectively) and CRT-P (6.7% vs. 5.7% and 25.6% vs. 23.8%, 
respectively) groups (Supplementary Table 4), although this was not statistically significant in the 
latter group, likely due to its small sample size. We have updated our results section to describe the 
differences in characteristics between device subgroups (quoted below). Our discussion has touched 
on this as quoted below. 
Under Results: 
“Within the CIED subgroups in the readmitted cohort, women were older in the PPM group and 
younger in the CRT-D group, while no difference in age between sexes was found in the CRT-P and 
ICD groups. (Supplementary Table 3).  Women in the PPM and CRT-P subgroups were more likely 
to have an urgent admission (vs. elective) or admission on a weekend compared to men, and had a 
higher prevalence of atrial fibrillation, chronic blood loss and deficiency anemias and heart failure 
but a lower prevalence of renal failure, coagulopathies and ventricular tachycardia.:
Under Discussion: 
“Our analysis highlights a disparity between device groups with regard to sex differences in causes 
of cardiac readmission. For example, although no difference was found in heart failure 
readmissions in the total cohort, women who had undergone PPM implantation were more likely to 
be readmitted for heart failure while other device groups either demonstrated no sex difference or 
lower rates of heart failure readmission amongst women. This is likely due to the observed higher 
prevalence of heart failure in women compared to men in the PPM group who may have not fulfilled 
the criteria for CRT device eligibility and are, therefore, presenting with frequent heart failure 
decompensations. Furthermore, the response rates to CRT are reported to be better in women than 
in men and that might contribute to the lack of sex-difference in HF hospitalizations among those 
patients receiving CRT. Our analysis of the total cohort also demonstrated higher rates of 
arrhythmias and device-related complications in women compared to men and, although this was 
also true in most device groups, there was no sex difference in either condition in patients 
undergoing CRT-P implantation. The latter is likely due to the smaller sample size of the CRT-P 
group in comparison to other groups (2.9% of the readmission cohort), masking any possible sex 
differences in this device group.”
Comment 2.- Please improve the presentation of Supplementary Figure 2: write the p value 
and modify the presentation of it. I think this figure should be included in the article and not 
only as suppl material.
Response: We thank the reviewer for this suggestion. We did initially want to include it in our main 
figures, but the journal submission rules restrict us from using more than 4 tables/figures combined 
in the main paper, which is why we had moved it to the supplements. We have added p-values to 
the figure itself and made improvements to its presentation (below) and it is now a main figure 
(Figure 1B). We hope that it is now satisfactory to the reviewer. 
Comment 3.- Table 1a: all p-values of the second page are missing, please add it. 
Response: Thank you. This has now been updated. 
Comment 4.- Discussion: compare with other device implantation (TAVI, stent in the context 
of AMI), do we have the same results?
Response: We have updated the discussion with findings from studies that looked at sex 
differences in difference cardiovascular procedure cohorts (quoted below). 
Under discussion: 
“There is a growing interest in the study of sex differences in readmissions after cardiovascular 
procedures such as PCI, TAVI and catheter ablation for AF. However, no study has examined 
these differences amongst those undergoing de novo CIED implantation.  Despite the baseline 
differences in patients undergoing each type of procedure, sex disparities in rates and causes 
of readmissions have been previously observed. In patients undergoing catheter ablation for 
AF, women were shown to have higher rates of all-cause, cardiac and arrhythmia-related 
(AF/atrial tachycardia) 30-day readmissions. In contrast, the rates of 30-day cardiac 
readmissions were higher in men compared to women after PCI in a national sample of more 
than 800,000 patients from the United States, and in a German registry analysis of patients 
undergoing TAVI, men were associated with increased odds of 1-year all-cause readmissions.”
Comment 5.- Supplementary Table 5: do we have any data of a higher incidence / prevalence 
of AF due to the higher Acute stroke/TIA, %?
Response: We thank the reviewer for raising this point. Indeed the prevalence of AF was much 
higher in women compared to men, especially in the readmitted group (49.4% vs. 43.6%; Table 1a) 
and this may account for the higher stroke rates in this group, especially if their anticoagulation was 
interrupted prior to, or shortly after, CIED implantation (especially in the case of warfarin). 
Comment 6.- Comment: This work constitutes part of a PhD for Dr Mohamed Mohamed that 
is supported by Medtronic Ltd. Dr Mohamed is not listed as author, please delete this 
comment.
Response: We are not sure why the authorship was not clarified, and we suspect it’s because the 
journal operates with a double-blind review policy, however, Mohamed Mohamed (myself) is the 
first author of the paper. Since my PhD funding comes from Medtronic Ltd, I am under an obligation 
to acknowledge their funding in the manuscript. We hope that you find this justification acceptable 
and we thank you for your thorough review of our manuscript.  
Highlights
 Largest study of sex differences in rates and causes of 30-day readmissions after CIED 
implantation. 
 No difference in all-cause readmissions was found between sexes over a 6-year period. 
 Women are at a greater risk of cardiac and device-related 30-day readmissions. 
 Reduction of procedural complications in women may improve their rates of cardiac 
readmission.
Abstract
Background: Women undergoing cardiac implantable electronic device (CIED) implantation 
are at a higher risk of procedure-related complications. The present study examined sex 
differences in rates and causes of 30-day readmissions following CIED implantation.
Methods: Using the United States Nationwide Readmissions Database (NRD), all adults who 
had undergone CIED implantation (cardiac resynchronization therapy (CRT), permanent 
pacemakers (PPM) and implantable cardioverter defibrillators (ICD)) between January 2010 
and September 2015 were included. We compared rates, trends and causes of 30-day 
readmissions between sexes, and examined associations between sex and outcomes (adjusted 
odds ratios (aOR) and 95% confidence intervals (CI))
Results: Out of 1,155,992 index hospitalizations for CIED implantation, 43.1% of the patients 
were women. All-cause 30-day readmissions were persistently higher in women than men but 
declined in both sexes over the study period, more so in women (women vs. men; 2010: 15.0% 
vs. 14.1%; 2015: 13.7% vs.13.4%). Women were at higher odds of readmission due to cardiac 
(aOR 1.22, 95%CI 1.20-1.24) and device-related complications (aOR 1.18, 95%CI 1.15-1.20) 
compared to men, but no difference odds of all-cause readmission were found between sexes 
(women: aOR 0.998, 95%CI 0.997-1.008). The most common cardiac and non-cardiac causes 
of readmission were heart failure and infection, respectively, and these were similar in both 
sexes (men vs. women: 17.8% vs. 17.6% and 10.7% vs. 10.8%, respectively). 
Conclusion: Women are persistently at higher risk of readmission due to cardiac causes and 
device-related complications compared to men over a six-year period, but no difference in all-
cause readmissions was found between sexes. 
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1
Introduction
The rate of cardiac implantable electronic device (CIED) implantations, including 
permanent pacemakers (PPM), cardiac resynchronization therapy with pacemakers (CRT-P) 
or defibrillators (CRT-D) and implantable cardioverter defibrillators (ICD), has grown 
considerably over the past decade, as has the rate of complications resulting from these 
procedures. [1-4] 
Unplanned hospital readmissions may occur as a consequence of such complications 
following CIED implantation, or may result in the sub-optimal provision of care during the 
index hospitalization.[5, 6] Hospital readmissions represent a significant burden for patients 
and healthcare systems, which may incur financial penalties as a result of high readmission 
rates, as they are frequently perceived as a measure of efficiency and quality of healthcare 
delivery.[7] Women have been shown to carry a higher risk of procedure-related complications 
following CIED implantation, partly due to their older age at the time of procedure, greater 
comorbid burden and anatomical differences compared to men.[8-11] Little is known about 
sex differences in unplanned readmissions, their temporal trends and causes in patients that 
have undergone CIED implantation.  
The present study examined national-level trends, causes and predictors of 30-day 
readmissions after hospitalizations for de novo CIED implantation between January 2010 and 
September 2015, stratified by sex and CIED type.
Methods 
Data Source
The Nationwide Readmissions Database (NRD) is a nationally representative sample 
of all-age, all-payer discharges from United States (U.S.) nonfederal hospitals sponsored by 






























































and Quality (AHRQ) and is a database of inpatient stays and readmissions that can be used to 
generate national estimates of readmissions. [12] The NRD dataset constitutes a stratified 
sample from 22 states with anonymized data from more than 17 million hospitalizations 
annually from 22 states and provides sampling weights to calculate national estimates that 
represent more than 50% of the U.S. population (approximately 36 million hospitalizations per 
annum). 
Study Design and Population
All adults (aged ≥18 years) who underwent de novo CIED implantation (PPM, CRT-P, 
CRT-D, and ICD) in an index hospitalization between January and November of the years 2010 
to 2014, and between January and August in 2015, were included, along with any records for 
readmission within 30 days of their index episode. We excluded index hospitalizations for 
CIED implantation in the last month of each study year (December in 2010-2014 and 
September in 2015) as these patients would not have not had 30-day follow-up and data was 
annualized and therefore impossible to track patients across years. Patient characteristics and 
in-hospital and readmission outcomes and procedures were extracted using the International 
Classification of Diseases, ninth revision (ICD-9) and Clinical Classification Software (CCS) 
diagnosis and procedural codes provided in the supplements (Supplementary Table 1). Causes 
of readmission were extracted using primary diagnoses CCS codes provided in Supplementary 
Table 2. The study cohort was stratified by gender into two groups; men and women. A flow 
diagram illustrating the selection process and missing variables in the present study is presented 
in Supplementary Figure 1. Cases excluded due to missing variables represented less than 
0.14% (n=1170) of the original dataset.  HCUP predefined discharge weights for each hospital 
were applied to the included records to produce the study population’s discharge estimates. 
Outcomes
We examined the difference in rates, trends and causes of 30-day readmissions between 






























































examined sex differences in clinical outcomes of the readmitted cohort, including the rates of 
in-hospital mortality, acute stroke or transient ischemic attack (TIA), acute kidney injury 
(AKI), bleeding, device-related infection and device revision or removal. 
Statistical Analysis
Statistical analysis was performed using SPSS version 24 (IBM Corp, Armonk, NY). 
Continuous variables are presented as medians with interquartile range (IQR) and were 
compared using the Kruskal-Wallis test. Categorical variables are presented as percentages and 
were analyzed using the chi-squared (X2) test. Trend analysis was performed using linear 
regression modeling with the inclusion of time (years) as a covariate.
Multivariable logistic regression models were constructed to assess the predictors of 
readmission from the index hospitalization variables, including female sex and type of CIED, 
measured by odds ratios (aOR, 95% confidence interval (CI)) adjusted for the following 
covariates: age, weekend admission, elective admission, primary expected payer, median 
household income, atrial fibrillation (AF), thrombocytopenia, ventricular tachycardia (VT) and 
fibrillation (VF), dyslipidemia, smoking status, previous AMI, previous coronary artery bypass 
graft (CABG), history of ischemic heart disease (IHD), previous PCI, previous cerebrovascular 
accidents (CVA) including stroke and TIA, family history of coronary artery disease (CAD), 
bed size of hospital, year of admission, Elixhauser comorbidities (acquired immune deficiency 
syndrome (AIDS), deficiency anemias, chronic blood loss anemia, rheumatoid 
arthritis/collagen vascular diseases, congestive heart failure, chronic pulmonary disease, 
coagulopathy, depression, diabetes (uncomplicated), diabetes with chronic complications, drug 
abuse, hypertension, hypothyroidism, liver disease, lymphoma, fluid and electrolyte disorders, 
metastatic cancer, other neurological disorders, obesity, peripheral vascular disorders (PVD), 
psychoses, pulmonary circulation disorders, chronic renal failure, solid tumor without 
metastasis, peptic ulcer disease excluding bleeding, valvular heart disease, and weight loss), 






























































bleeding, thoracic and cardiac complications). Thoracic complications were defined as a 
composite of acute pneumothorax or hemothorax, with or without drainage, or thoracic 
vascular injury, while cardiac complications were defined as a composite of cardiac 
tamponade, hemopericardium, pericardiocentesis. 
Results
A total of 1,155,992 hospitalizations for CIED implantation were recorded between 
January 2010 and August 2015. The percentage of women undergoing CIED implantation 
remained relatively stable through the study period (2010: 42.3% vs. 2015: 43.0%, p<0.001).
Several key differences in patient demographics and procedure-related outcomes were 
observed between men and women in the index hospitalization for CIED implantation (Table 
1a). Overall, women were older, more likely to be admitted during a weekend, less likely to 
have an elective admission, and had a higher prevalence of previous CVA, concomitant AF, 
anemia (chronic and iron deficiency), hypertension, hypothyroidism, fluid and electrolyte 
disorders, and valvular heart disease. However, there was a higher prevalence of cardiovascular 
comorbidities amongst men such as heart failure, previous coronary-related disease and 
coronary intervention (previous MI, PCI and CABG), and diabetes. While these patterns of sex 
differences were observed in both the readmission and non-readmission groups, the prevalence 
of all comorbidities was much higher in the readmission group. Within the CIED subgroups in 
the readmitted cohort, women were older in the PPM group and younger in the CRT-D group, 
while no difference in age between sexes was found in the CRT-P and ICD groups. 
(Supplementary Table 3).  Women in the PPM and CRT-P subgroups were more likely to have 
an urgent admission (vs. elective) or admission on a weekend compared to men, and had a 
higher prevalence of atrial fibrillation, chronic blood loss and deficiency anemias and heart 






























































There was no difference in the rate of PPM implantation between sexes although 
women were less likely than men to undergo implantation of other types of CIEDs (CRT-P: 
42% vs. 58%, CRT-D: 27.9% vs. 72.1%, ICD: 28.1% vs. 71.9%). 
30-day Readmissions
The overall rate of 30-day readmissions was 14.0% while the rate of cardiac 
readmissions was 5.6% (40 % of all readmissions), and both were observed to be higher in 
women than in men (overall: 14.4% vs. 13.6% and cardiac: 5.8% vs. 5.5%, p<0.001 for both). 
Women were more likely to be readmitted earlier than men (mean time: 12 vs. 13 days, 
p<0.001). The rates of 30-day readmission (all-cause, cardiac and device-related) declined in 
both sexes from 2010 to 2015 and, although the rates were higher in women in earlier years, 
this gap was progressively eliminated in later years (Figure 1). In multivariable analysis, female 
sex was independently associated with increased odds of readmission due to cardiac causes 
(aOR 1.22 95% CI 1.20 - 1.24, p<0.001), Supplementary Table 5, Figure 2A) and, more 
specifically, device-related complications (aOR 1.26 95% CI 1.19- 1.33, p<0.001), both of 
which persisted throughout the study period. (Figure 3A and Figure 3B). The odds for all-cause 
readmission for women were compared to men (aOR 0.998 95% CI 0.997 - 1.008, p=0.660). 
Subgroup analyses according to the type of CIED demonstrated significantly higher 
rates of cardiac readmission in women who have undergone PPM and CRT-P implantation 
(38.2% vs. 33.4% and 43.2% vs. 40.8%, respectively, p<0.001 for both) compared to men, and 
lower rates of cardiac readmission in women who have undergone ICD implantation (47.1% 
vs. 49.4%, p<0.001). (Figure 1B) There were no sex differences in patients who had undergone 
CRT-D implantation (men: vs. women: 49.0% vs. 49.2%, p=0.850). 
The top non-cardiac causes of readmission were due to infectious, respiratory, PVD, 
renal, gastrointestinal and stroke/TIA diagnoses. (Table 1b) Women were more likely to be 






























































renal and PVD-related presentations. However, there was no difference between sexes in 
readmissions due to infection and stroke/TIA.
Overall, heart failure was the most common cardiac cause of readmission. While there 
was no difference in heart failure readmissions between sexes in the total CIED cohort (men 
17.8% vs. women 17.6%, p=0.242) (Table 1b, Supplementary Figure 2) and across most CIED 
subtypes (CRT-P, CRT-D and ICD), women were more likely to be readmitted due to heart 
failure in the PPM group (Supplementary Table 4). Arrhythmias and device-related 
complications were the next most common cardiac causes of readmission and were both higher 
in women (9.1% vs. 8.5% and 3.5% vs. 3.0%, respectively, p<0.001 for both) in the total CIED 
cohort. (Table 1b, Supplementary Figure 2). This pattern was observed across all CIED 
subtypes for device-related complications, however, women in the PPM and CRT-P were more 
likely to be readmitted for arrhythmias compared to men, while those in the CRT-D and ICD 
groups were less likely to be readmitted for arrhythmias compared to men. (Supplementary 
Table 4) 
Regression analysis was performed to identify predictors of readmission due to cardiac 
causes from variables related to the index admission. In comparison to PPM, all complex types 
of CIED were associated with increased odds of cardiac readmission with the highest being 
CRT-D and ICD groups (aOR CRT-P: 1.19 95% CI 1.13 - 1.25, CRT-D: 1.46 95% CI 1.42 - 
1.50, ICD: 1.46 95% CI 1.43 - 1.50). (Figure 2B) All in-hospital procedure-related 
complications (AKI, acute stroke, thoracic and cardiac complications and post-procedural 
hemorrhage) were also associated with increased odds of cardiac readmission, the highest 
being cardiac complications (aOR 1.42 95% CI 1.24 - 1.62) and AKI during index admission 
(aOR 1.29 95% CI 1.26 - 1.32) (Figure 2B). Other variable associated with increased odds of 
cardiac readmission included previous history of heart failure, VT, AF, deficiency anemias, 































































Readmission episode in-hospital outcomes
 The rates of all-cause mortality and device revision or removal in the 30-day 
readmissions episodes were 4.9% and 5.2%, respectively, with no difference between sexes 
(Supplementary Table 6, Figure 6). Women were more likely to experience acute stroke/TIA 
during the readmission episode (2.4% vs. 1.9%) but less likely to experience all other 
complications (AKI: 13.7% vs. 15.6%, bleeding: 4.9% vs. 5.2%, and device-related infection: 
2.8% vs. 3.7%). 
Discussion
 The present study is the largest to examine national-level sex differences in trends and 
predictors of 30-day readmissions in over 1 million patients with de novo CIED implantations 
and provides several novel findings. We report a decline in the rates of all-cause and cardiac 
30-day readmissions in both sexes over time, more so in women who were at a much higher 
risk of readmission in earlier years compared to men.  We show that women have increased 
odds of cardiac readmission and are more likely to be readmitted with device-related 
complications compared to men throughout the study duration. Finally, we show that there was 
no sex difference in in-hospital mortality amongst those readmitted and that women were less 
likely to experience adverse events in their readmissions. The requirement for device revision 
or extraction, was however similar in both sexes. 
There is a growing interest in the study of sex differences in readmissions after 
cardiovascular procedures such as PCI, TAVI and catheter ablation for AF. [13-15] However, 
no study has examined these differences amongst those undergoing de novo CIED 
implantation.  Despite the baseline differences in patients undergoing each type of procedure, 
sex disparities in rates and causes of readmissions have been previously observed. In patients 






























































cardiac and arrhythmia-related (AF/atrial tachycardia) 30-day readmissions.[15] In contrast, 
the rates of 30-day cardiac readmissions were higher in men compared to women after PCI in 
a national sample of more than 800,000 patients from the United States, [14] and in a German 
registry analysis of patients undergoing TAVI, men were associated with increased odds of 1-
year all-cause readmissions. [13]
To the best of our knowledge, the present study is the first to examine trends of 
readmissions following CIED implantation according to sex. Pasupula et al. reported a 
reduction in 30-day readmissions (14% to 13%) after CIED implantation over a five-year 
period (2010 to 2014).[16] However, their descriptive analysis did not compare sex differences 
in readmission trends, particularly given that sex has previously been shown to be an 
independent risk factor for procedure-related complications. [8] Our analysis shows a 
downward trend of 30-day all-cause readmissions over a five-year horizon in both sexes and 
that women were more likely to be readmitted after CIED implantation, although the gap 
between sexes has narrowed in later years. This reduction in overall rate of readmission in both 
sexes, especially women, could be attributed to improvements in the quality of care and 
discharge planning offered to patients undergoing CIED implantation. However, a concerning 
finding is the persistent increased risk of cardiac and device-related readmissions amongst 
women throughout the study period despite advancements in implantation techniques in recent 
years (e.g. ultrasound guidance, dedicated training fellowships for operators). [9, 17-19] We 
believe that this is likely due to the higher rate of procedure-related complications in women 
during the index admission as demonstrated in our study as well as in previous reports. [8]
One of the key aspects of our analysis was the comparison of sex differences in cardiac 
and non-cardiac causes of 30-day readmission.  While previous studies have looked at 
readmissions following CIED implantation, no study has examined the trend and overall causes 
of these readmissions according to sex and type of CIED. [8, 20-22] In a national registry 






























































difference in hospitalizations for device-related complications between sexes as part of their 
secondary outcomes (women: 3.4% vs. men: 3.5%, OR 1.05 [0.97, 1.13]) in over 80000 
patients.[8] However, their analysis was based on a much smaller cohort with a lower 
proportion of women (37.9% vs. 43.1%) and patients in receipt of complex pacing (CRT and 
ICD: 24.2% vs. 36.6%) compared to our study and only focused on hospitalizations for device-
related complications. In contrast, our analysis provides insight into the common cardiac and 
non-cardiac causes of 30-day readmission after CIED implantation. Although we report a 
similarity in the most common cardiac (heart failure) and non-cardiac (infection) causes of 
readmission between sexes, we show that other common cardiac causes of readmission such 
as arrhythmias and device-related complications are more likely to occur in women. Even after 
adjustment for baseline and procedural differences (device type and complications in the index 
episode), women remained at increased odds of 30-day readmissions for cardiac (aOR 1.22 
[1.20, 1.24]) and device-related causes (aOR 1.26 [1.19, 1.33]) compared to men.  
Our analysis highlights a disparity between device groups with regard to sex differences 
in causes of cardiac readmission. For example, although no difference was found in heart 
failure readmissions in the total cohort, women who had undergone PPM implantation were 
more likely to be readmitted for heart failure while other device groups either demonstrated no 
sex difference or lower rates of heart failure readmission amongst women. This is likely due to 
the observed higher prevalence of heart failure in women compared to men in the PPM group 
who may have not fulfilled the criteria for CRT device eligibility and are, therefore, presenting 
with frequent heart failure decompensations. Furthermore, the response rates to CRT are 
reported to be better in women than in men and that might contribute to the lack of sex-
difference in HF hospitalizations among those patients receiving CRT.[23] Our analysis of the 
total cohort also demonstrated higher rates of arrhythmias and device-related complications in 
women compared to men and, although this was also true in most device groups, there was no 






























































likely due to the smaller sample size of the CRT-P group in comparison to other groups (2.9% 
of the readmission cohort), masking any possible sex differences in this device group. A further 
possible explanation to the variation in causes of readmission between device groups may be 
related to differences in baseline risk profile between sexes undergoing each type of device or 
differences in the receipt of evidence-based therapy between sexes (e.g. angiotensin converting 
enzyme inhibitors in heart failure and beta-blockers or amiodarone in patients with ventricular 
arrhythmias).[24-26] These findings emphasize the importance of incorporating sex as well as 
device type when risk assessing patients undergoing CIED therapy. 
Our multivariable analysis identifies several important baseline and procedure-related 
predictors of cardiac readmission other than sex. Complex device groups (CRT and ICD) were 
associated with significantly increased odds of cardiac readmission (19-46%) compared to 
PPM, as were complications during the index admission (cardiac, thoracic, bleeding 
complications and AKI) and comorbidities such as heart failure, arrhythmias (VT and AF), and 
chronic pulmonary disease. The present findings emphasize the importance of timely follow 
up of women and other high-risk patients undergoing CIED implantation, as recommended by 
current guidelines, which may have a positive impact on their short-term readmission rates. 
Limitations
There are several limitations to our study. First, the administrative nature of the NRD 
database is subject to coding inaccuracies and potential misclassification bias. However, the 
use of ICD-9 codes from such databases has been previously validated for the purpose of 
cardiovascular research as well as for capturing CIED complications. [27, 28] Secondly, the 
NRD dataset does not provide information on the indication for CIED implantation (e.g. type 
of arrhythmia and primary vs. secondary prevention in CRT-D and ICD procedures) and 
operator experience, and therefore we were unable to adjust for the differences in these 






























































have an insignificant effect in a large analysis of ICD outcomes in women. [29] Thirdly, we 
were only able to analyze the first eleven months of every calendar year in order to examine 
30-day readmissions within that year since NRD does not allow tracking of individual patients 
over multiple years. Finally, NRD does not capture post discharge mortality, which acts as a 
competing risk for readmission. Nevertheless, we believe that the present study provides a 
valuable insight into the sex differences in trends and causes of 30-day readmissions following 
CIED implantation in a nationwide cohort. 
Conclusion
In a nationwide analysis of CIED implantations we find that women were at a higher 
risk of all-cause 30-day readmissions and that this risk has gradually declined to a similar rate 
compared to men over the study years. We also conclude that women were at a persistently 
higher risk of cardiac and device-related readmissions compared to men over a six- year period. 
This may be partly due to the higher risk of complications in women after CIED implantation, 
which was also an independent predictor of readmission in our analysis.  These findings 
emphasize the need for further work on strategies to reduce the risk of procedure-related 
complications in women, which may have a positive impact on their rates of cardiac and 
device-related readmissions. The present study reports important predictors of cardiac 
readmission, including CIED type and procedure-related complications during index 
admission, and provides insight into those individuals at higher risk when discharging and 
arranging follow-up after CIED implantation. 
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Figures and Legends: 
Figure 1A. Trends of all-cause, cardiac and device-related 30-day readmissions 
according to sex
Caption: p<0.001 for trend; *2015: January to August only
Figure 1B. Proportion of cardiac (vs. non-cardiac) readmissions according to sex and 
CIED type
Figure 2. A) Baseline and B) Index procedure-related predictors of 30-day cardiac 
readmissions*
Caption: * all predictors generated from a single multivariate regression model; § non-significant; † p<0.01; ‡ 
p<0.001; 
Figure 3. Temporal trend of adjusted odds ratio (aOR) of 30-day readmissions due to A) 
cardiac causes and B) device-related complications in women compared to men











































































Number of weighted 
discharges 454856 332759 787615 <0.001 205574 162803 368377 <0.001
Type of CIED, % <0.001 <0.001
PPM 59.5 78.1 67.4 54.0 74.4 63.0
CRT-P 2.6 2.5 2.5 2.8 2.9 2.9
CRT-D 14.3 7.5 11.4 17.2 8.4 13.3
ICD 23.6 11.9 18.6 25.9 14.4 20.8
Age (years), median (IQR) 73 (64, 81) 77 (68,84) 75 (65,83) <0.001 74 (64,82) 78 (68,85) 76 (66,83) <0.001
Elective Admission, % 26.7 22.1 24.8 <0.001 22.0 18.3 20.3 <0.001
Weekend admission, % 16.6 18.4 17.4 <0.001 18.3 19.9 19.0 <0.001
Primary expected payer, % <0.001 <0.001
Medicare 71.2 79.3 74.6 76.5 83.1 79.4
Medicaid 4.6 4.4 4.5 6.3 5.6 6.0
Private Insurance 19.4 13.7 17.0 13.4 9.3 11.6
Self-pay 1.9 1.2 1.6 1.5 1.0 1.2
No charge 0.2 0.2 0.2 0.2 0.1 0.2
Other 2.7 1.2 2.1 2.2 0.9 1.6
Median Household Income 
(Percentile), % <0.001 <0.001
0-25th 26.0 28.0 26.9 28.9 30.0 29.4
26-50th 25.7 26.1 25.9 25.4 26.0 25.7
51-75th 24.4 24.2 24.3 23.7 23.6 23.7
76-100th 23.8 21.7 22.9 21.9 20.3 21.2
Cardiac Arrest, % 4.4 4.0 4.2 4.2 4.3 4.3
Ventricular Tachycardia, % 9.2 5.2 7.5 11.7 6.4 9.3
Ventricular Fibrillation, % 4.4 2.9 3.7 4.1 2.8 3.5
Comorbidities, %
Dyslipidemia 55.5 50.4 53.3 <0.001 53.0 48.9 51.2 <0.001
Smoking 29.9 17.8 24.8 <0.001 28.8 17.8 24.0 <0.001
Atrial Fibrillation 36.3 39.8 37.8 <0.001 43.6 49.4 46.1 <0.001
Thrombocytopenia 5.1 3.6 4.4 <0.001 6.1 4.6 5.4 <0.001









History of IHD 54.9 34.4 46.2 61.5 43.5 53.6
Previous PCI 13.7 7.7 11.2 14.2 9.5 12.1
Previous CABG 16.9 6.4 12.5 18.0 8.3 13.7
Previous CVA 7.2 8.2 7.6 8.4 9.5 8.9
Family history of CAD 4.2 3.8 4.0 3.1 2.6 2.9
AIDS 0.1 0.0 0.0 0.1 0.0 0.1
Alcohol abuse 3.3 0.8 2.3 3.8 0.9 2.5
Deficiency anemias 12.7 16.4 14.3 21.2 25.2 23.0
Chronic Blood loss anemia 1.5 3.8 2.4 1.8 4.7 3.1
RA/collagen vascular
diseases 0.4 0.6 0.5 0.8 1.1 0.9
Heart Failure 41.5 35.0 38.8 56.6 51.6 53.3
Chronic pulmonary disease 18.0 18.4 18.2 25.9 26.0 26.0
Coagulopathy 6.6 4.9 5.9 8.6 6.7 7.8
Depression 5.5 9.9 7.4 7.4 12.2 9.5
Diabetes 27.2 24.3 26.0 30.8 28.9 30.0
Diabetes with complications 5.3 4.6 5.0 8.7 7.7 8.2
Drug abuse 1.4 0.8 1.2 2.0 1.2 1.6
Hypertension 71.0 73.5 72.1 72.4 75.0 73.6
Hypothyroidism 9.2 23.3 15.1 10.7 24.1 16.6
Liver disease 1.4 1.1 1.3 2.3 1.6 2.0
Lymphomas 0.7 0.6 0.7 1.1 0.9 1.0
Fluid and electrolyte 
disturbances 18.4 23.4 20.5 26.7 32.0 29.0
Metastatic cancer 0.4 0.4 0.4 0.8 0.7 0.7
Other neurological disorders 6.3 7.5 6.8 8.1 9.4 8.7
Obesity 12.1 12.9 12.4 12.7 14.7 13.6
Paralysis 1.6 1.7 1.6 2.5 2.6 2.6
Peripheral vascular disease 10.4 8.0 9.4 14.9 11.5 13.4
Psychoses 1.9 2.5 2.1 2.9 3.6 3.2
Pulmonary circulation disorder 0.6 0.9 0.8 1.2 1.9 1.5









Solid tumor without metastases 1.5 0.9 1.2 2.2 1.3 1.8
Valvular heart disease 1.4 1.9 1.6 2.5 3.0 2.7
Weight loss 2.2 2.6 2.3 3.9 4.4 4.1
Dementia 1.6 2.2 1.9 2.1 2.7 2.4
Hospital bed size, %
Small 8.2 9.0 8.5 7.3 8.1 7.6
Medium 20.9 22.0 21.4 20.4 21.7 21.0
Large 70.9 69.0 70.1 72.3 70.2 71.4
PPM: permanent pacemaker; CRT-P & CRT-D: cardiac resynchronization therapy - pacemaker or - defibrillator, respectively; ICD: implantable 
cardioverter-defibrillator; IQR: interquartile range; AMI: acute myocardial infarction; IHD: ischemic heart disease; CABG: coronary artery bypass 
graft; PCI: percutaneous coronary intervention; CAD: coronary artery disease; CVA: cerebrovascular accidents. 
Table 1b. Causes of readmission according to sex
Group (% within category) Men Women Total p-value
Number of weighted readmissions 104358 83554 187912
A. Cause of readmission 0.755
Cardiac, % 40.4 40.3 40.3
Non-cardiac, % 59.6 59.7 59.7
B. Specific Non-cardiac causes, %
Infectious 10.7 10.8 10.7 0.538
Respiratory 5.1 6.2 5.6 <0.001
Bleeding 2.2 2.1 2.2 0.360
Peripheral Vascular Disease 3.8 3.3 3.5 <0.001
Renal 3.4 2.9 3.2 <0.001
Genitourinary 2.2 2.2 2.2 0.596
Gastrointestinal 4.6 5.0 4.8 <0.001
TIA/Stroke 2.7 2.8 2.8 0.137
Trauma 1.7 2.3 2.0 <0.001
Endocrine/Metabolic 1.5 1.7 1.6 0.002
Neuropsychiatric 2.9 2.6 2.7 <0.001
Hematology-Oncology 2.3 2.1 2.2 0.006
Rheumatology 0.2 0.1 0.1 <0.001
ENT 0.3 0.4 0.3 0.261
Dermatological 0.2 0.1 0.1 0.049
Poisoning 0.2 0.3 0.3 0.237
Syncope 1.5 1.4 1.5 0.121
C. Specific cardiac causes, %
Device-related complications 3.0 3.5 3.2 <0.001
Arrhythmia 8.5 9.1 8.8 <0.001
Heart failure 17.8 17.6 17.7 0.242
Chest pain 2.2 2.3 2.3 0.161
Conduction disorders 0.3 0.3 0.3 0.873
Valve disorders 0.6 0.6 0.6 0.982
Circulatory disorder (hypo- or 
hypertension) 2.0 2.1 2.0 0.751
Pericarditis 1.3 1.5 1.4 <0.001
Coronary artery disease (including 
angina) 2.6 1.5 2.1 <0.001
Acute myocardial infarction 1.9 1.8 1.9 0.010
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Supplementary Figure 1. Flow chart of cohort selection























Supplementary Table 1. ICD-9 diagnosis and procedure codes 






Dyslipidemia CCS D 53
Smoking Status ICD-9 D V15.82, 305.1 
AF ICD-9 D 427.31
History of IHD ICD-9 D 414.00-07, 414.2-9
Previous MI ICD-9 D 412
Previous PCI ICD-9 D V45.82 
Previous CABG ICD-9 D V45.81 
Family history of CAD ICD-9 D V17.3 
Previous CVA (TIA and Stroke) ICD-9 D V12.54
Dementia (Presenile, Senile, Vascular 
and Alzheimer’s)
ICD-9 D 290.10-13, 290.20-21, 
290.40-43, 294.10-11, 331.0
Thrombocytopenia ICD-9 D 287.5,287.49
Heart Failure ICD-9, CCS D 428.x plus CCS: 108, 
7.2.11.1, 7.2.11.2
Ventricular Tachycardia/Fibrillation ICD-9 D 427.1 (VT – paroxysmal 
and/or sustained), 427.41 
(VF)
In-hospital procedures and outcomes
PPM ICD-9 P [37.70 or 37.71 or 37.72 or 
37.73] + [37.80 or 37.81 or 
37.82 or 37.83]
CRT-P ICD-9 P 00.50
CRT-D ICD-9 P 00.51
ICD ICD-9 P 37.94 or (37.95+37.96)
Acute ischemic stroke/transient 
ischemic attack
ICD-9 D 433.01, 433.11, 433.21, 
433.31, 433.81, 433.91, 
434.01, 434.11, 434.91, 
435.0-1, 435.8-9, 436
Acute hemorrhagic stroke 
(subarachnoid, intracerebral 
hemorrhage)
ICD-9 D 431,432.x, 430
Post-procedural hemorrhage ICD-9 D 998.11, 285.1
Acute kidney injury ICD-9 D 584*
Shock during admission ICD-9 D 785.51
Hemopericardium ICD-9 D 423.0
Pericardiocentesis ICD-9       P 37.0
Cardiac tamponade ICD-9 D 423.3
Coronary dissection ICD-9 D 414.12
Pneumothorax ICD-9 D 512.89, 512.1, 860.0-1
Hemothorax ICD-9 D 860.2-3
Chest Drain Insertion CCS P 39
Cardiac Arrest ICD-9 D 427.5
Device related infection ICD-9 D 996.61
Fever ICD-9 D 780.60-64
Bacteraemia/Viremia ICD-9 D 790.7/790.8
Septicemia ICD-9 D 038.x
Thoracic/Upper Limb Vascular injury ICD-9 D 901.x, 903.1, 903.8-9, 900.1
Supplementary Table 2: Clinical classification software codes for Readmissions Causes
Causes of readmission CCS 
code
Diagnosis
127 Chronic obstructive pulmonary disease and bronchiectasis
128 Asthma
130 Pleurisy, pneumothorax, pulmonary collapse
131 Respiratory failure, insufficiency and arrest
132 Lung disease due to external agents
133 Other lower respiratory disease
134 Other upper respiratory disease
Respiratory









9 Sexually transmitted infection
76 Meningitis
77 Encephalitis
78 Other CNS infection and poliomyelitis
90 Inflammation or infection of eye
122 Pneumonia
123 Influenza
124 Acute and chronic tonsillitis
125 Acute bronchitis
126 Other upper respiratory infections
129 Aspiration pneumonitis
135 Intestinal infection
197 Skin and subcutaneous tissue infections
Infection
201 Infective arthritis and osteomyelitis (except that caused by 
tuberculosis or
sexually transmitted disease)
60 Acute posthaemorrhagic anemia
153 Gastrointestinal hemorrhage
Bleeding
182 Hemorrhage during pregnancy; abrutio placenta; placenta previa
114 Peripheral and visceral atherosclerosis
115 Aortic, peripheral and visceral artery aneurysms
116 Aortic and peripheral arterial embolism or thrombosis
117 Other circulatory disease
118 Phlebitis, thrombophlebitis and thromboembolism
Peripheral vascular 
disease
119 Varicose veins of lower extremities
159 Urinary tract infectionGenitourinary
160 Calculus of the urinary tract
161 Other diseases of kidney and ureters
162 Other diseases of bladder and urethra
163 Genitourinary symptoms and ill-defined conditions
164 Hyperplasia of prostate
165 Inflammatory conditions of the male genital organs
166 Other male genital disorders
170 Prolapse of female genital organs
175 Other female genital disorders
215 Genitourinary congenital anomalies
156 Nephritis; nephrosis; renal sclerosis
157 Acute and unspecified renal failure
Renal disease
158 Chronic kidney disease
138 Esophageal disorders
139 Gastroduodenal ulcer (except hemorrhage)
140 Gastritis and duodenitis
141 Other disorders of stomach and duodenum
142 Appendicitis and other appendiceal conditions
143 Abdominal hernia
144 Regional enteritis and ulcerative colitis
145 Intestinal obstruction without hernia
146 Diverticulosis and diverticulitis
147 Anal and rectal conditions
148 Peritonitis and intestinal abscess
149 Biliary tract disease
150 Liver disease; alcohol-related
151 Other liver diseases
152 Pancreatic disorders (not diabetes)
154 Noninfectious gastroenteritis
155 Other gastrointestinal disorders
214 Digestive congenital anomalies
222 Hemolytic jaundice and perinatal jaundice
250 Nausea and vomiting
Gastrointestinal
251 Abdominal pain
109 Acute cerebrovascular disease
110 Occlusion of stenosis of precerebral arteries
111 Other and ill-defined cerebrovascular disease
112 Transient cerebral ischemia
TIA/stroke
113 Late effects of cerebrovascular disease
207 Pathological fracture
225 Joint disorders and dislocations; trauma-related
226 Fracture of neck of femur (hip)
227 Spinal cord injury
228 Skull and face fractures
229 Fracture of upper limb
Trauma
230 Fracture of lower limb
231 Other fractures
232 Sprains and strains
233 Intracranial injury
234 Crushing injury or internal injury
235 Open wounds of head; neck; and trunk
236 Open wounds of extremities
239 Superficial injury; contusion
244 Other injuries and conditions due to external causes
260 All (external causes of injury and poisoning)
48 Thyroid disorders
49 Diabetes mellitus without complication
50 Diabetes mellitus with complication
51 Other endocrine disorders
53 Disorders of lipid metabolism
58 Other nutritional and endocrine/metabolic disorders
Endocrine/metabolic
186 Diabetes or abnormal glucose tolerance complicating pregnancy; 
childbirth or the puerperium
650 Adjustment disorders
651 Anxiety disorders
652 Attention-deficit, conduct, and disruptive behavior disorders
653 Delirium, dementia, and amnestic and other cognitive disorders
654 Developmental disorders
655 Disorders usually diagnosed in infancy and childhood or 
adolescence
656 Impulse control disorders, NEC
657 Mood disorders
658 Personality disorders
659 Schizophrenia and other psychotic disorders
660 Alcohol-related disorders
661 Substance-related disorders
662 Suicide and intentional self-inflicted injury
663 Screening and history of mental health and substance abuse codes
670 Miscellaneous mental health disorders
79 Parkinson's disease
80 Multiple sclerosis
81 Other hereditary and degenerative nervous system conditions
82 Paralysis
83 Epilepsy, convulsions
84 Headache including migraine
85 Coma, stupor and brain damage
95 Other nervous system disorders
216 Nervous system congenital anomalies
650 Adjustment disorders
651 Anxiety disorders
652 Attention-deficit, conduct, and disruptive behavior disorders
Neuropsychiatric
653 Delirium, dementia, and amnestic and other cognitive disorders
654 Developmental disorders
655 Disorders usually diagnosed in infancy and childhood or 
adolescence
656 Impulse control disorders, NEC
657 Mood disorders
658 Personality disorders
659 Schizophrenia and other psychotic disorders
660 Alcohol-related disorders
661 Substance-related disorders
662 Suicide and intentional self-inflicted injury
663 Screening and history of mental health and substance abuse codes
670 Miscellaneous mental health disorders
11 Cancer of head and neck
12 Cancer of esophagus
13 Cancer of stomach
14 Cancer of colon
15 Cancer of rectum and anus
16 Cancer of liver and intrahepatic bile ducts
17 Cancer of pancreas
18 Cancer of other GI organs, peritoneum
19 Cancer of bronchus, lung
20 Cancer of other respiratory and intrathoracic
21 Cancer of bone and connective tissue
22 Melanoma of skin
23 Other non-epithelial cancer of skin
24 Cancer of breast
25 Cancer of uterus
26 Cancer of cervix
27 Cancer of ovary
28 Cancer of other female genital organs
29 Cancer of prostate
30 Cancer of testis
31 Cancer of other male genital organs
32 Cancer of bladder
33 Cancer of kidney and renal pelvis
34 Cancer of other urinary organs
35 Cancer of brain and nervous system









43 Malignant neoplasm without specification of site
44 Neoplasm of unspecified nature or uncertain behaviour
46 Benign neoplasm of uterus
47 Other and unspecified benign neoplasm
59 Deficiency and other anemias
61 Sickle cell anemia
62 Coagulation and hemorrhagic disorders
63 Disease of white blood cells
64 Other hematologic conditions
Rheumatology problem 54 Gout and other crystal arthropathies
86 Cataract
87 Retinal detachment defects, vascular occlusion and retinopathy
88 Glaucoma
89 Blindness and vision defects
Opthalmology problem
91 Other eye disorders
92 Otitis media and related conditions
93 Conditions associate with dizziness or vertigo
ENT problem
94 Other ear and sense organ disorder
Non-specific chest pain 102 Non-specific chest pain
136 Disorders of teeth and jawOral health problem
137 Diseases of mouth; excluding dental
174 Female infertility





181 Other complications of pregnancy
184 Early or threatened labor
185 Prolonged pregnancy
187 Malposition; malpresentation
188 Fetopelvic disproportion; obstruction
189 Previous C-section
190 Fetal distress and abnormal forces of labor
191 Polyhydramnios and other problems of amniotic cavity
192 Umbilical cord complication
193 OB-related trauma to perineum and vulva
194 Forceps delivery
195 Other complications of birth; puerperium affecting management of 
mother
196 Other pregnancy and deliver including normal
218 Liveborn
219 Short gestation; low birth weight; and fetal growth retardation




224 Other perinatal conditions
198 Other inflammatory condition of skin
199 Chronic ulcer of skin
Dermatology problem
200 Other skin disorders
241 Poisoning by psychotrophic agents
242 Poisoning by other medication and drugs
Poisoning
243 Poisoning by nonmedical substances
Syncope 245 Syncope
10 Immunization and screening for infectious disease
45 Maintenance chemotherapy, radiotherapy
52 Nutritional deficiencies




121 Other diseases of veins and lymphatics
167 Nonmalignant breast conditions




202 Rheumatoid arthritis and related disease
203 Osteoarthritis
204 Other non-traumatic joint disorders
205 Spondylosis; intervertebral disc disorders; other back problems
206 Osteoporosis
208 Acquired foot deformities
209 Other acquired deformities
210 Systemic lupus erythematosus and connective tissue disorders
211 Other connective tissue disease
212 Other bone disease and musculoskeletal deformities
217 Other congenital anomalies
237 Complication of device; implant or graft
238 Complications of surgical procedure or medical care
240 Burns
246 Fever of unknown origin
247 Lymphadenitis
248 Gangrene
252 Malaise and fatigue
253 Allergic reactions






258 Other screening for suspected conditions (not mental disorders or 
infectious disease)
259 Residual codes; unclassified
Heart failure 108 Congestive heart failure non-hypertensive
106 Cardiac dysrhythmiaArrhythmia
107 Cardiac arrest and ventricular fibrillation
Conduction disorder 105 Conduction disorders
Valve disorders 96 Heart valve disorder
98 Essential hypertension
99 Hypertension with complications and secondary hypertension




Pericarditis 97 Peri-, endo- and myocarditis, cardiomyopathy
Coronary artery disease
including angina
101 Coronary atherosclerosis and other heart disease
Acute myocardial 
infarction
100 Acute myocardial infarction
103 Pulmonary heart disease
104 Other and ill-defined heart disease
Others (cardiac)
213 Cardiac and circulatory congenital anomalies
Supplementary Table 3. Patient characteristics of readmitted patients according to CIED subtype
















Number of weighted 
discharges 56531 62664 - 3011 2327 - 17372 6719 - 27445 11845 -


















Elective Admission, % 10.5 8.6 <0.001 11.1 9.3 0.031 12.0 12.0 0.898 8.7 8.8 0.703
Weekend admission, 
% 23.3 24.1 0.002 23.2 25.6 0.040 22.5 23.3 0.205 22.8 23.0 0.674
Primary expected 
payer, % <0.001 <0.001 <0.001 <0.001
Medicare 82.4 87.1 81.9 84.8 75.9 75.0 62.2 63.7
Medicaid 4.0 3.7 3.0 4.6 6.7 9.1 13.3 15.7
Private Insurance 10.7 7.5 11.8 7.9 14.1 12.9 18.4 16.6
Self-pay 0.9 0.7 0.6 0.9 0.9 1.5 2.6 2.3
No charge 0.1 0.1 0.0 0.1 0.2 0.1 0.4 0.2




<0.001 <0.001 <0.001 <0.001
0-25th 26.6 28.0 23.2 31.4 29.4 34.3 33.9 37.3
26-50th 26.0 26.1 26.6 22.7 26.2 26.9 23.8 25.2
51-75th 24.2 24.5 26.9 21.8 22.7 21.7 22.4 20.6
76-100th 23.1 21.4 23.3 24.1 21.7 17.2 19.9 16.9
Cardiac Arrest, % 0.8 0.9 0.492 0.7 0.9 0.401 1.4 0.8 <0.001 1.0 1.0 0.570
Ventricular 
Tachycardia, % 2.7 1.6 <0.001 4.5 2.6 <0.001 9.8 7.6 <0.001 10.8 9.8 0.002
Ventricular 
Fibrillation, % 0.5 0.4 <0.001 0.6 0.5 0.582 1.8 2.1 0.280 2.7 2.8 0.619
















Cardiogenic Shock, % 1.1 0.8 <0.001 1.4 2.1 0.047 3.0 2.9 0.576 2.7 2.2 0.010
Comorbidities, %
Dyslipidemia 47.1 44.2 <0.001 48.0 42.4 <0.001 49.0 44.8 <0.001 48.0 42.7 <0.001
Smoking 23.5 14.2 <0.001 22.5 17.0 <0.001 25.3 17.7 <0.001 28.5 21.1 <0.001
Atrial Fibrillation 43.4 51.2 <0.001 56.7 62.0 <0.001 43.6 39.8 <0.001 34.9 29.7 <0.001
Thrombocytopenia 5.2 3.5 <0.001 5.0 3.7 0.019 5.7 4.5 <0.001 4.8 3.8 <0.001
Previous AMI 9.9 6.9 <0.001 12.2 8.2 <0.001 18.5 13.3 <0.001 20.6 16.3 <0.001
History of IHD 52.2 39.4 <0.001 65.4 45.5 <0.001 71.8 54.3 <0.001 67.4 55.4 <0.001
Previous PCI 11.1 7.9 <0.001 11.9 9.5 0.005 15.3 12.2 <0.001 17.8 13.0 <0.001
Previous CABG 16.9 8.2 <0.001 22.3 10.2 <0.001 26.0 11.8 <0.001 20.4 13.1 <0.001
Previous CVA 9.1 9.4 0.101 9.1 9.8 0.410 7.4 7.1 0.459 7.0 7.8 0.009
Family history of CAD 1.6 1.6 0.659 1.5 2.1 0.140 2.4 2.2 0.237 2.5 2.3 0.391
AIDS 0.1 0.0 <0.001 0.1 0.1 0.796 0.1 0.0 0.112 0.3 0.2 0.192
Alcohol abuse 2.4 0.5 <0.001 2.0 0.3 <0.001 2.4 1.0 <0.001 4.4 1.6 <0.001
Deficiency anemias 28.4 30.9 <0.001 28.1 28.9 0.530 25.6 30.2 <0.001 24.1 29.8 <0.001
Chronic Blood loss 
anemia 1.8 4.5 <0.001 2.0 3.8 <0.001 1.7 4.3 <0.001 1.5 5.0 <0.001
RA/collagen vascular
diseases 1.6 1.6 0.212 1.2 1.7 0.136 0.8 1.1 0.038 1.0 1.3 0.009
Heart Failure 42.3 48.4 <0.001 71.5 74.6 0.011 83.5 84.3 0.166 70.2 70.2 0.971
Chronic pulmonary 
disease 24.9 24.8 0.741 27.1 29.0 0.122 28.8 30.3 0.017 27.1 29.6 <0.001
Coagulopathy 7.6 5.5 <0.001 7.1 5.8 0.062 8.7 7.1 <0.001 7.5 6.1 <0.001
Depression 7.9 11.8 <0.001 8.2 13.9 <0.001 7.6 12.7 <0.001 7.9 14.1 <0.001
Diabetes 28.8 27.4 <0.001 31.5 27.8 0.003 34.2 34.3 0.905 32.0 31.3 0.216
Diabetes with 
complications 8.3 6.7 <0.001 9.8 5.6 <0.001 8.2 8.0 0.601 8.6 9.7 <0.001
Drug abuse 1.1 0.8 <0.001 0.8 0.5 0.146 1.7 1.4 0.157 3.6 3.0 0.002
















Hypertension 70.1 72.1 <0.001 64.3 69.8 <0.001 65.1 65.6 0.467 67.5 66.9 0.204
Hypothyroidism 12.2 25.1 <0.001 12.9 27.7 <0.001 12.2 21.1 <0.001 7.9 16.9 <0.001
Liver disease 2.3 1.7 <0.001 2.6 0.9 <0.001 2.7 1.5 <0.001 2.8 2.5 0.117
Lymphomas 1.3 1.0 <0.001 1.3 0.4 0.001 1.0 0.9 0.316 0.8 0.9 0.153
Fluid and electrolyte 
disturbances 30.2 34.2 <0.001 33.9 31.5 0.067 31.3 34.7 <0.001 28.4 32.0 <0.001
Metastatic cancer 1.6 0.8 <0.001 1.6 1.2 0.336 0.4 0.6 0.027 0.3 0.5 0.001
Other neurological 
disorders 10.1 9.4 <0.001 7.8 8.0 0.731 4.5 4.8 0.295 4.8 6.3 <0.001
Obesity 8.8 11.4 <0.001 9.5 11.5 0.015 11.0 15.0 <0.001 12.3 16.0 <0.001
Paralysis 2.9 2.6 0.005 3.1 2.2 0.057 1.3 1.9 <0.001 1.9 1.8 0.423
Peripheral vascular 
disease 12.8 10.0 <0.001 13.4 8.2 <0.001 13.3 9.4 <0.001 12.3 9.9 <0.001
Psychoses 3.3 3.3 0.818 2.2 2.2 0.936 2.4 2.8 0.165 3.6 4.3 0.004
Pulmonary circulation 
disorder 4.2 5.6 <0.001 6.2 5.8 0.523 3.4 5.0 <0.001 3.1 4.1 <0.001
Renal failure (chronic) 32.1 27.8 <0.001 39.3 30.3 <0.001 41.9 33.1 <0.001 33.2 28.8 <0.001
Solid tumor without 
metastases 2.8 1.3 <0.001 1.9 1.0 0.005 1.0 1.1 0.254 1.3 0.8 <0.001
Valvular heart disease 11.7 12.2 0.002 12.3 11.8 0.576 8.8 10.5 <0.001 6.5 7.6 <0.001
Weight loss 6.7 6.4 0.113 7.6 9.3 0.031 5.2 5.0 0.426 4.9 4.9 0.842
Dementia 3.6 3.3 0.004 2.4 1.2 0.002 0.9 0.9 0.999 0.7 0.6 0.981
Hospital bed size, % <0.001 0.073 0.628 0.005
Small 10.5 10.9 9.6 7.8 8.3 8.3 7.9 7.3
Medium 22.3 23.3 24.8 24.7 21.4 20.8 20.0 21.2
Large 67.1 65.8 65.6 67.5 70.3 70.9 72.0 71.5
Supplementary Table 4. Cardiac causes of readmission according to type of device and sex 
PPM CRT-P CRT-D ICD



















complications 2.7 3.4 <0.001 2.3 2.4 0.647 3.2 4.2 <0.001 3.3 3.8 0.028
Arrhythmia 6.6 9.2 <0.001 5.7 6.7 0.136 9.4 8.3 0.01 12.1 9.7 <0.001
Heart failure 12.4 15.4 <0.001 23.8 25.6 0.126 26.2 26.0 0.743 23.2 23.2 0.975
Chest pain 2.3 2.3 0.826 1.2 2.1 0.016 1.7 2.6 <0.001 2.6 2.4 0.456
Conduction disorders 0.2 0.2 0.899 0.3 0.1 0.135 0.3 0.5 0.001 0.3 0.4 0.119




1.7 2.0 <0.001 2.2 1.8 0.320 2.8 2.5 0.262 2.3 1.9 0.004




2.9 1.4 <0.001 1.6 1.0 0.056 2.3 1.2 <0.001 2.5 2.0 0.001
Acute myocardial 
infarction 2.1 1.8 <0.001 1.8 1.3 0.168 1.7 1.7 0.881 1.7 1.9 0.123
Supplementary Table 5. Predictors of cardiac cause 30-day readmission*
Variable aOR [95% CI] p-value
Women 1.22 [1.20, 1.24] <0.001
Index admission related variables
PPM (reference) - -
CRT-P 1.19 [1.13, 1.25] <0.001
CRT-D 1.46 [1.42, 1.50] <0.001
ICD 1.46 [1.43, 1.50] <0.001
Acute kidney injury 1.29 [1.26, 1.32] <0.001
Post-procedural hemorrhage 1.05 [1.01, 1.10] 0.014
Cardiac complications 1.42 [1.24, 1.62] <0.001
Thoracic complications 1.18 [1.13, 1.23] <0.001
Baseline predictors
Age in years at admission 0.99 [0.99, 1.00] 0.173
Elective admission 0.80 [0.79, 0.82] <0.001
Weekend admission 1.06 [1.04, 1.08] <0.001
VT 1.26 [1.22, 1.29] <0.001
Dyslipidemia 0.93 [0.91, 0.95] <0.001
Smoking 0.98 [0.97, 1.00] <0.001
AF 1.42 [1.40, 1.44] <0.001
History of ischemic heart disease 1.31 [1.28, 1.34] <0.001
Previous percutaneous coronary intervention 1.04 [1.02, 1.07] <0.001
Acquired immune deficiency syndrome 1.63 [1.26, 2.11] <0.001
Deficiency anemia 1.17 [1.15, 1.20] <0.001
Chronic blood loss anemia 1.01 [0.97, 1.06] 0.587
Rheumatoid arthritis/collagen vascular diseases 0.95 [0.86, 1.04] 0.244
Heart failure 1.40 [1.37, 1.43] <0.001
Chronic pulmonary disease 1.25 [1.23, 1.28] <0.001
Coagulopathy 1.18 [1.12, 1.25] <0.001
Depression 1.03 [1.00, 1.06] 0.080
Diabetes, uncomplicated 1.07 [1.05, 1.09] 0.000
Diabetes with chronic complications 1.09 [1.05, 1.12] 0.000
Hypertension 0.99 [0.97, 1.01] 0.136
Hypothyroidism 1.01 [0.99, 1.04] 0.223
Liver disease 1.05 [0.99, 1.12] 0.088
Lymphoma 1.30 [1.20, 1.41] <0.001
Fluid and electrolyte disorders 1.20 [1.18, 1.23] <0.001
Other neurological disorders 0.92 [0.89, 0.96] <0.001
Obesity 1.02 [0.99, 1.04] 0.15
Peripheral vascular disorders 1.07 [1.04, 1.09] <0.001
Psychoses 1.02 [0.97, 1.07] 0.457
Pulmonary circulation disorders 1.02 [0.95, 1.10] 0.607
Chronic renal failure 1.39 [1.36, 1.42] <0.001
Solid tumor without metastasis 1.00 [0.93, 1.07] 0.922
Valvular disease 0.95 [0.90, 1.01] 0.072
*All predictors are derived from index admission records; PPM: permanent pacemaker; CRT-P & CRT-D: 
cardiac resynchronization therapy - pacemaker or - defibrillator, respectively; ICD: implantable cardioverter-
defibrillator
Supplementary Table 6. Clinical outcomes of 30-day readmission episode according to 
sex 
Variable/Group (% of cohort) Men(55.8)
Women
(44.2) Total p-value
All-cause mortality, % 4.9 5.0 4.9 0.384
Acute stroke/TIA, % 1.9 2.4 2.1 <0.001
Acute kidney injury, % 15.6 13.7 14.7 <0.001
Bleeding, % 5.2 4.9 5.0 0.004
Device-related infection, % 3.7 2.8 3.3 <0.001
Device revision or removal, % 5.3 5.2 5.2 0.269
